The Efficiency of Hydroxychloroquine for the Treatment of Primary Sjögren’s Syndrome: A Systematic Review and Meta-Analysis

Objectives: This meta-analysis was conducted to evaluate the effects of hydroxychloroquine (HCQ) in the treatment of primary Sjögren’s syndrome (pSS).Methods: Nine databases were searched for data collection. We used clinical features, including involvement in superficial tissues and visceral system...

Full description

Bibliographic Details
Main Authors: Xuan Wang, Tongyangzi Zhang, Zizhen Guo, Jincheng Pu, Farooq Riaz, Run Feng, Xingxing Fang, Jiamin Song, Yuanyuan Liang, Zhenzhen Wu, Shengnan Pan, Jianping Tang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.693796/full
_version_ 1819099416922947584
author Xuan Wang
Tongyangzi Zhang
Zizhen Guo
Jincheng Pu
Farooq Riaz
Run Feng
Xingxing Fang
Jiamin Song
Yuanyuan Liang
Zhenzhen Wu
Shengnan Pan
Jianping Tang
author_facet Xuan Wang
Tongyangzi Zhang
Zizhen Guo
Jincheng Pu
Farooq Riaz
Run Feng
Xingxing Fang
Jiamin Song
Yuanyuan Liang
Zhenzhen Wu
Shengnan Pan
Jianping Tang
author_sort Xuan Wang
collection DOAJ
description Objectives: This meta-analysis was conducted to evaluate the effects of hydroxychloroquine (HCQ) in the treatment of primary Sjögren’s syndrome (pSS).Methods: Nine databases were searched for data collection. We used clinical features, including involvement in superficial tissues and visceral systems, and experimental findings, including Schirmer’s test, unstimulated salivary flow rate (uSFR), C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) and immunoglobulins (IgG, IgM and IgA) as major outcome measures. The Downs and Black quality assessment tool and RevMan 5.3 were used to assess the methodological quality and statistical analysis, respectively.Results: Thirteen studies with pSS patients, consisting of two randomized controlled studies, four retrospective studies and seven prospective studies were analyzed. Results showed that HCQ treatment significantly improved the oral symptoms of pSS patients compared to non-HCQ treatment (P = 0.003). Similar trends favoring HCQ treatment were observed for uSFR (p = 0.05), CRP (p = 0.0008), ESR (p < 0.00001), IgM (p = 0.007) and IgA (p = 0.05). However, no significant improvement was observed in other clinical features, including ocular involvement, fatigue, articular lesions, pulmonary, neurological and lymphoproliferative symptoms, renal organs and other experimental parameters in the HCQ treatment group compared to the non-HCQ treatment group.Conclusion: HCQ treatment showed moderate efficacy to improve oral symptoms, uSFR, ESR, CRP, IgM and IgA. However, HCQ could not alleviate organ-specific systemic involvement.Systematic Review Registration:We have registered on the PROSPERO [https://www.crd.york.ac.uk/PROSPERO/], and the registration number is identifier [CRD42020205624]
first_indexed 2024-12-22T00:46:32Z
format Article
id doaj.art-f8da5081d7b24f42b7ec93f23707d33f
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-12-22T00:46:32Z
publishDate 2021-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-f8da5081d7b24f42b7ec93f23707d33f2022-12-21T18:44:33ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122021-09-011210.3389/fphar.2021.693796693796The Efficiency of Hydroxychloroquine for the Treatment of Primary Sjögren’s Syndrome: A Systematic Review and Meta-AnalysisXuan Wang0Tongyangzi Zhang1Zizhen Guo2Jincheng Pu3Farooq Riaz4Run Feng5Xingxing Fang6Jiamin Song7Yuanyuan Liang8Zhenzhen Wu9Shengnan Pan10Jianping Tang11Department of Rheumatology and Immunology, Tongji Hospital, Tongji University School of Medicine, Shanghai, ChinaDepartment of Rheumatology and Immunology, Tongji Hospital, Tongji University School of Medicine, Shanghai, ChinaDepartment of Immunology, Shanghai Jiaotong University School of Medicine, Shanghai, ChinaDepartment of Rheumatology and Immunology, Tongji Hospital, Tongji University School of Medicine, Shanghai, ChinaDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Xi’an Jiaotong University Health Science Center, Xi’an, ChinaDepartment of Rheumatology and Immunology, Tongji Hospital, Tongji University School of Medicine, Shanghai, ChinaDepartment of Rheumatology and Immunology, Tongji Hospital, Tongji University School of Medicine, Shanghai, ChinaDepartment of Rheumatology and Immunology, Tongji Hospital, Tongji University School of Medicine, Shanghai, ChinaDepartment of Rheumatology and Immunology, Tongji Hospital, Tongji University School of Medicine, Shanghai, ChinaDepartment of Rheumatology and Immunology, Tongji Hospital, Tongji University School of Medicine, Shanghai, ChinaDepartment of Rheumatology and Immunology, Tongji Hospital, Tongji University School of Medicine, Shanghai, ChinaDepartment of Rheumatology and Immunology, Tongji Hospital, Tongji University School of Medicine, Shanghai, ChinaObjectives: This meta-analysis was conducted to evaluate the effects of hydroxychloroquine (HCQ) in the treatment of primary Sjögren’s syndrome (pSS).Methods: Nine databases were searched for data collection. We used clinical features, including involvement in superficial tissues and visceral systems, and experimental findings, including Schirmer’s test, unstimulated salivary flow rate (uSFR), C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) and immunoglobulins (IgG, IgM and IgA) as major outcome measures. The Downs and Black quality assessment tool and RevMan 5.3 were used to assess the methodological quality and statistical analysis, respectively.Results: Thirteen studies with pSS patients, consisting of two randomized controlled studies, four retrospective studies and seven prospective studies were analyzed. Results showed that HCQ treatment significantly improved the oral symptoms of pSS patients compared to non-HCQ treatment (P = 0.003). Similar trends favoring HCQ treatment were observed for uSFR (p = 0.05), CRP (p = 0.0008), ESR (p < 0.00001), IgM (p = 0.007) and IgA (p = 0.05). However, no significant improvement was observed in other clinical features, including ocular involvement, fatigue, articular lesions, pulmonary, neurological and lymphoproliferative symptoms, renal organs and other experimental parameters in the HCQ treatment group compared to the non-HCQ treatment group.Conclusion: HCQ treatment showed moderate efficacy to improve oral symptoms, uSFR, ESR, CRP, IgM and IgA. However, HCQ could not alleviate organ-specific systemic involvement.Systematic Review Registration:We have registered on the PROSPERO [https://www.crd.york.ac.uk/PROSPERO/], and the registration number is identifier [CRD42020205624]https://www.frontiersin.org/articles/10.3389/fphar.2021.693796/fullhydroxychloroquineSjögren’s syndromesystematic reviewmeta-analysistreatmemt
spellingShingle Xuan Wang
Tongyangzi Zhang
Zizhen Guo
Jincheng Pu
Farooq Riaz
Run Feng
Xingxing Fang
Jiamin Song
Yuanyuan Liang
Zhenzhen Wu
Shengnan Pan
Jianping Tang
The Efficiency of Hydroxychloroquine for the Treatment of Primary Sjögren’s Syndrome: A Systematic Review and Meta-Analysis
Frontiers in Pharmacology
hydroxychloroquine
Sjögren’s syndrome
systematic review
meta-analysis
treatmemt
title The Efficiency of Hydroxychloroquine for the Treatment of Primary Sjögren’s Syndrome: A Systematic Review and Meta-Analysis
title_full The Efficiency of Hydroxychloroquine for the Treatment of Primary Sjögren’s Syndrome: A Systematic Review and Meta-Analysis
title_fullStr The Efficiency of Hydroxychloroquine for the Treatment of Primary Sjögren’s Syndrome: A Systematic Review and Meta-Analysis
title_full_unstemmed The Efficiency of Hydroxychloroquine for the Treatment of Primary Sjögren’s Syndrome: A Systematic Review and Meta-Analysis
title_short The Efficiency of Hydroxychloroquine for the Treatment of Primary Sjögren’s Syndrome: A Systematic Review and Meta-Analysis
title_sort efficiency of hydroxychloroquine for the treatment of primary sjogren s syndrome a systematic review and meta analysis
topic hydroxychloroquine
Sjögren’s syndrome
systematic review
meta-analysis
treatmemt
url https://www.frontiersin.org/articles/10.3389/fphar.2021.693796/full
work_keys_str_mv AT xuanwang theefficiencyofhydroxychloroquineforthetreatmentofprimarysjogrenssyndromeasystematicreviewandmetaanalysis
AT tongyangzizhang theefficiencyofhydroxychloroquineforthetreatmentofprimarysjogrenssyndromeasystematicreviewandmetaanalysis
AT zizhenguo theefficiencyofhydroxychloroquineforthetreatmentofprimarysjogrenssyndromeasystematicreviewandmetaanalysis
AT jinchengpu theefficiencyofhydroxychloroquineforthetreatmentofprimarysjogrenssyndromeasystematicreviewandmetaanalysis
AT farooqriaz theefficiencyofhydroxychloroquineforthetreatmentofprimarysjogrenssyndromeasystematicreviewandmetaanalysis
AT runfeng theefficiencyofhydroxychloroquineforthetreatmentofprimarysjogrenssyndromeasystematicreviewandmetaanalysis
AT xingxingfang theefficiencyofhydroxychloroquineforthetreatmentofprimarysjogrenssyndromeasystematicreviewandmetaanalysis
AT jiaminsong theefficiencyofhydroxychloroquineforthetreatmentofprimarysjogrenssyndromeasystematicreviewandmetaanalysis
AT yuanyuanliang theefficiencyofhydroxychloroquineforthetreatmentofprimarysjogrenssyndromeasystematicreviewandmetaanalysis
AT zhenzhenwu theefficiencyofhydroxychloroquineforthetreatmentofprimarysjogrenssyndromeasystematicreviewandmetaanalysis
AT shengnanpan theefficiencyofhydroxychloroquineforthetreatmentofprimarysjogrenssyndromeasystematicreviewandmetaanalysis
AT jianpingtang theefficiencyofhydroxychloroquineforthetreatmentofprimarysjogrenssyndromeasystematicreviewandmetaanalysis
AT xuanwang efficiencyofhydroxychloroquineforthetreatmentofprimarysjogrenssyndromeasystematicreviewandmetaanalysis
AT tongyangzizhang efficiencyofhydroxychloroquineforthetreatmentofprimarysjogrenssyndromeasystematicreviewandmetaanalysis
AT zizhenguo efficiencyofhydroxychloroquineforthetreatmentofprimarysjogrenssyndromeasystematicreviewandmetaanalysis
AT jinchengpu efficiencyofhydroxychloroquineforthetreatmentofprimarysjogrenssyndromeasystematicreviewandmetaanalysis
AT farooqriaz efficiencyofhydroxychloroquineforthetreatmentofprimarysjogrenssyndromeasystematicreviewandmetaanalysis
AT runfeng efficiencyofhydroxychloroquineforthetreatmentofprimarysjogrenssyndromeasystematicreviewandmetaanalysis
AT xingxingfang efficiencyofhydroxychloroquineforthetreatmentofprimarysjogrenssyndromeasystematicreviewandmetaanalysis
AT jiaminsong efficiencyofhydroxychloroquineforthetreatmentofprimarysjogrenssyndromeasystematicreviewandmetaanalysis
AT yuanyuanliang efficiencyofhydroxychloroquineforthetreatmentofprimarysjogrenssyndromeasystematicreviewandmetaanalysis
AT zhenzhenwu efficiencyofhydroxychloroquineforthetreatmentofprimarysjogrenssyndromeasystematicreviewandmetaanalysis
AT shengnanpan efficiencyofhydroxychloroquineforthetreatmentofprimarysjogrenssyndromeasystematicreviewandmetaanalysis
AT jianpingtang efficiencyofhydroxychloroquineforthetreatmentofprimarysjogrenssyndromeasystematicreviewandmetaanalysis